teva semaglutide First Generic GLP-1 Injection OK'd for Weight Loss for oral use Endor Health Lists Sandoz, Apotex,
Description
Today, it is seen by many as a chronic disease that, because of links to other conditions like diabetes, heart disease, and high blood pressure, warrants continuous treatment

Pills may lower barriers for people who are hesitant about injections while still targeting appetite regulation, blood sugar control, and weight loss through the same biological pathways
Medical Disclaimer This article is here to inform and educate, not to replace your actual doctor
Eli Lilly launched Mounjaro in India in March 2025, followed by Novo Nordisks Wegovy in June 2025
